July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
February 2026
The global oral oncology specialty pharmacy market is driven by rising cancer burden, increasing use of oral anticancer drugs, and expansion of specialty pharmacy services worldwide.
July 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
July 2026
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,740 million by 2035 from USD 880 million in 2025 with a notable CAGR of 12.03%.
July 2026
The global oral syringes market size was valued at USD 1.84 billion in 2025 and is projected to reach around USD 3.37 billion by 2035, with a CAGR of 6.24%.
July 2026
The North America biosolids management market size surpassed USD 570 million in 2025 and is predicted to reach around USD 937.35 million by 2035, registering a CAGR of 5.10%.
July 2026
The Europe biosolids management market size was estimated at USD 420 million in 2025 and is projected to be worth around USD 698.61 million by 2035, growing at a CAGR of 5.22%.
July 2026
The India biosolids management market size is calculated at USD 61.05 Million in 2025 and is predicted to attain around USD 127.59 Million by 2035, expanding at a CAGR of 7.65%.
July 2026
The U.S. biosolids management market size accounted for USD 399 million in 2025 and is predicted to touch around USD 699.86 million by 2035, growing at a CAGR of 5.78%.
July 2026
The orally disintegrating tablet market size was evaluated at USD 15.73 billion in 2025 and is expected to surpass around USD 33.98 billion by 2035 with a CAGR of 8.01%.
July 2026
The global outpatient oncology infusion market size is predicted to attain around USD 265.10 billion by 2035 from USD 96.77 billion in 2025 with a notable CAGR of 10.60%.
July 2026
The global behavioral health market size was calculated at USD 184.94 billion in 2025 and is expected to hit around USD 349.88 billion by 2035 with a notable CAGR of 6.58%.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
July 2026
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
July 2026
The U.S. behavioral health market is projected to grow from USD 94.82 billion in 2025 to USD 174.78 billion by 2035, registering a CAGR of 6.31%.
July 2026
The oncology market size surpassed USD 250.88 billion in 2025 and is expected to hit around USD 732.45 billion by 2035 with a CAGR of 11.31%.
July 2026
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
July 2026
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
July 2026
The solid oxide fuel cell market size was calculated at USD 3.85 billion in 2025 and is projected to reach around USD 32.14 billion by 2034 with a CAGR of 26.60%.
July 2026
The global solid rocket engine market is growing as demand rises for cost-effective, reliable propulsion in defense and space applications.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
Oncology proteomics market to grow significantly by 2035, driven by cancer research advances, biomarker discovery, and rising demand for precision medicine.
June 2026
The oral iron supplements market is growing steadily, driven by rising anemia cases, increased health awareness, and improved global healthcare access.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com